Tin tức & Cập nhật

The presence of reflux disease, no matter the type, appears to elevate the risk for colonic neoplasia, suggests a recent study.

New drug applications approved by US FDA as of 16-31 March 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Adherence to sulfur microbial diet (SMD) appears to increase the risk of chronic kidney disease (CKD), irrespective of genetic risk, suggests a study.

Visualization technology guided by the integrated real-time imaging system (IRIS) results in a significant decrease in procedural duration and improvements in the first-attempt success rate for postpyloric feeding-tube placement in critically ill patients, according to a study.

In patients with diarrhoea-predominant inflammatory bowel disease (IBS-D), a low FODMAP diet (LFD) intervention and rifaximin treatment both result in improved outcomes, as shown in a study.

The different types of nutrition support have varying effect on the nutritional status and clinical outcomes of critically ill patients in the intensive care unit (ICU), reports a study. However, parenteral nutrition (PN) combined with enteral nutrition (EN) appears to be most effective in improving clinical outcomes and nutrition support in these patients.

Borderline personality disorder (BPD) is associated with higher risks of a wide range of physical diseases and increased mortality from all causes, natural causes, and external causes, according to a 16-year population-based cohort study in Hong Kong.

A review of 19 meta-analyses shows mixed results on the effects of multivitamin and mineral (MVM) supplementation on health outcomes.

Individuals with atopic dermatitis or allergic rhinitis are at increased risk of inflammatory bowel disease (IBD), as suggested in a retrospective nested case–control study.

The first-in-class KRAS G12D–targeted protein degrader setidegrasib has demonstrated antitumour activity in patients with previously treated advanced non–small-cell lung cancer (NSCLC) or pancreatic ductal adenocarcinoma harbouring the KRAS G12D mutation, according to a phase I study.